|
|
Volumn 16, Issue 5, 2005, Pages 779-785
|
|
Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,3 BUTADIENE DERIVATIVE;
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
GW 707;
LIGAND;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MEMBRANE PROTEIN;
MESSENGER RNA;
MITOGEN ACTIVATED PROTEIN KINASE;
NITRILE;
PROTEIN KINASE INHIBITOR;
SIGNAL PEPTIDE;
SREBP CLEAVAGE ACTIVATING PROTEIN;
SREBP CLEAVAGE-ACTIVATING PROTEIN;
STEROID;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYME ACTIVATION;
GENE EXPRESSION;
GENETICS;
HUMAN;
METABOLISM;
PROMOTER REGION;
SIGNAL TRANSDUCTION;
TRANSACTIVATION;
TUMOR CELL LINE;
BUTADIENES;
CELL LINE, TUMOR;
ENZYME ACTIVATION;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
GENE EXPRESSION;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
LIGANDS;
MAP KINASE SIGNALING SYSTEM;
MEMBRANE PROTEINS;
NITRILES;
PROMOTER REGIONS (GENETICS);
PROTEIN KINASE INHIBITORS;
RECEPTORS, LDL;
RNA, MESSENGER;
STEROIDS;
TRANS-ACTIVATION (GENETICS);
|
|
EID: 33644630516
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.16.5.779 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
